Antagonists of immunosuppressive macrolides
    2.
    发明授权
    Antagonists of immunosuppressive macrolides 失效
    免疫抑制大环内酯拮抗剂

    公开(公告)号:US5342935A

    公开(公告)日:1994-08-30

    申请号:US985088

    申请日:1992-12-02

    IPC分类号: C07H19/01 C07D267/00

    CPC分类号: C07H19/01

    摘要: Hydroxymacrolides and derivatives of the general structural Formula I: ##STR1## have been prepared from suitable precursors by oxidation at C-20. These macrolides are useful as antagonists of FK-506-type immunosuppressants. The compounds of the present invention are useful for modifying dosages of FK-506-type immunosuppressants in the treatment of autoimmune diseases, infectious diseases and/or the prevention of rejection of foreign organ transplants. In addition, the compounds of the present invention have utility as antidotes for overdoses of FK-506-type immunosuppressants.

    摘要翻译: 羟基甲基丙烯酰胺和一般结构式I的衍生物:我已经通过在C-20氧化由合适的前体制备。 这些大环内酯可用作FK-506型免疫抑制剂的拮抗剂。 本发明的化合物可用于修饰FK-506型免疫抑制剂在治疗自身免疫性疾病,感染性疾病和/或预防外来器官移植排斥反应中的剂量。 此外,本发明的化合物可用作FK-506型免疫抑制剂过量的解毒剂。

    Antagonists of immunosuppressive macrolides
    3.
    发明授权
    Antagonists of immunosuppressive macrolides 失效
    免疫抑制大环内酯拮抗剂

    公开(公告)号:US5190950A

    公开(公告)日:1993-03-02

    申请号:US766908

    申请日:1991-09-26

    IPC分类号: C07H19/01

    CPC分类号: C07H19/01

    摘要: A method for the modification of treatment of an immuno regulatory disorder or disease with an FK-506-type immunosuppressive macrolide comprising the administration to a mammalian species in need of such modification of an effective amount of a compound of the formula I. ##STR1##

    摘要翻译: 一种用FK-506型免疫抑制性大环内酯治疗免疫调节性疾病或疾病的方法,包括向需要这种修饰的哺乳动物物种施用有效量的式I化合物。 一世